SCHEMBL3855301

SCHEMBL3855301

COc1ccc(C(=O)N2c3cc(F)ccc3-c3ccccc3C2C)cc1

nearest known ligand 0.48

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.44
ALDH1A1 P00352 4/20 0.43
LMNA P02545 3/20 0.43
TSHR P16473 1/20 0.43
HTT P42858 1/20 0.43
P2RY1 P47900 3/20 0.42
PTGDR2 Q9Y5Y4 1/20 0.42
SMN1; SMN2 Q16637 2/20 0.42
NPC1 O15118 1/20 0.42
HPGD P15428 1/20 0.42
RAB9A P51151 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
KMT2A Q03164 4/20 0.41
MEN1 O00255 3/20 0.41
CRHBP P24387 1/20 0.41
CRHR2 Q13324 1/20 0.41
SCN9A Q15858 1/20 0.41
HSD11B1 P28845 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3855280 0.92 ALDH1A1 (0.45) GAAALDH1A1LMNATSHRHTT
SCHEMBL3854734 0.91 ALDH1A1 (0.46) GAAALDH1A1LMNATSHRHTT
SCHEMBL3860967 0.89 ALDH1A1 (0.49) ALDH1A1LMNATSHRHTTPTGDR2
SCHEMBL3855449 0.87 KMT2A (0.46) KMT2AMEN1
SCHEMBL3860354 0.87 KMT2A (0.46) KMT2AMEN1
SCHEMBL3855998 0.87 KMT2A (0.46) KMT2AMEN1
SCHEMBL3859881 0.87 BCHE (0.50) GAAALDH1A1LMNAP2RY1PTGDR2
SCHEMBL3857987 0.85 HSD11B1 (0.45) GAAALDH1A1LMNAHTTSMN1; SMN2
SCHEMBL3860822 0.81 KMT2A (0.43) KMT2AMEN1
SCHEMBL3860772 0.81 KMT2A (0.43) KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7585871-B2 4-{[(6R)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; 3-{[(6S)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; 4-{[(6S)-8-fluoro-6-methylphenanthridin-5(6H)-yl]carbonyl}phenol; cytokine expression WYETH (US) 2009-09-08 US disclosed
EP-1784391-A1 PHENANTHRIDINE CARBONYL PHENOLS AS CYTOKINE EXPRESSION MODULATORS Wyeth (US) 2007-05-16 EP disclosed
US-20060058337-A1 Phenanthridine carbonyl phenols WYETH (US) 2006-03-16 US disclosed
WO-2006028875-A1 PHENANTHRIDINE CARBONYL PHENOLS AS CYTOKINE MODULATORS WYETH (US) 2006-03-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060058337-A1 Phenanthridine carbonyl phenols MT-CO2, PAH, CBR3 GAA 2431/4885ALDH1A1 985/4885LMNA 1313/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.